ILF3 and hepatocellular carcinoma: This finding leads us to hypothesize that, in addition to NF90, both USP11 and TRIM55 may exert distinct effects on the activation and suppression of the TGFβ/Smad signaling, which potentially play pivotal roles in the progression of HCC.